Opening book details…
About this book
Nivolumab Plus Ipilimumab in Advanced Salivary Gland Cancer: a Phase 2 Trial by Joris L. Vos & Bharat Burman & Swati Jain & Conall W. R. Fitzgerald & Eric J. Sherman & Lara A. Dunn & James V. Fetten & Loren S. Michel & Anuja Kriplani & Kenneth K. Ng & Juliana Eng & Vatche Tchekmedyian & Sofia Haque & Nora Katabi & Fengshen Kuo &... is a book available to read on EtoBox.
- Author
- Joris L. Vos & Bharat Burman & Swati Jain & Conall W. R. Fitzgerald & Eric J. Sherman & Lara A. Dunn & James V. Fetten & Loren S. Michel & Anuja Kriplani & Kenneth K. Ng & Juliana Eng & Vatche Tchekmedyian & Sofia Haque & Nora Katabi & Fengshen Kuo &...
- Publisher
- Springer US
- Published
- 2023
- Language
- EN
More by Joris L. Vos & Bharat Burman & Swati Jain & Conall W. R. Fitzgerald & Eric J. Sherman & Lara A. Dunn & James V. Fetten & Loren S. Michel & Anuja Kriplani & Kenneth K. Ng & Juliana Eng & Vatche Tchekmedyian & Sofia Haque & Nora Katabi & Fengshen Kuo &...
Similar books
- Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Early-stage Triple-negative Breast Cancer: a Phase 2 Adaptive Trial — Iris Nederlof & Olga I. Isaeva & Manon Graaf & Robbert C. A. M. Gielen & Noor A. M. Bakker & Adrianne L. Rolfes & Hannah Garner & Bram Boeckx & Joleen J. H. Traets & Ingrid A. M. Mandjes & Michiel Maaker & Thomas Brussel & Maksim Chelushkin & Elisa... (2024)
- High- or Low-dose Preoperative Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer: the Phase 1B NABUCCO Trial — Jeroen Dorp & Christodoulos Pipinikas & Britt B. M. Suelmann & Niven Mehra & Nick Dijk & Giovanni Marsico & Maurits L. Montfoort & Sophie Hackinger & Linde M. Braaf & Tauanne Amarante & Charlaine Steenis & Kirsten McLay & Antonios Daletzakis & Daan... (2023)
- Neoadjuvant Chemotherapy Plus Nivolumab with or Without Ipilimumab in Operable Non-small Cell Lung Cancer: the Phase 2 Platform NEOSTAR Trial — Tina Cascone & Cheuk H. Leung & Annikka Weissferdt & Apar Pataer & Brett W. Carter & Myrna C. B. Godoy & Hope Feldman & William N. William & Yuanxin Xi & Sreyashi Basu & Jing Sun & Shalini S. Yadav & Frank R. Rojas Alvarez & Younghee Lee & Aditya... (2023)
- Gemcitabine and Cisplatin Plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: a Phase 2 Trial — Matthew D. Galsky & Siamak Daneshmand & Sudeh Izadmehr & Edgar Gonzalez-Kozlova & Kevin G. Chan & Sara Lewis & Bassam El Achkar & Tanya B. Dorff & Jeremy Paul Cetnar & Brock O. Neil & Anishka Damp#x02019; Souza & Ronac Mamtani & Christos Kyriakopoulos &... (2024)
- Ipilimumab with or Without Nivolumab in PD-1 or PD-L1 Blockade Refractory Metastatic Melanoma: a Randomized Phase 2 Trial — Ari VanderWalde & Shay L. Bellasea & Kari L. Kendra & Nikhil I. Khushalani & Katie M. Campbell & Philip O. Scumpia & Lawrence F. Kuklinski & Frances Collichio & Jeffrey A. Sosman & Alexandra Ikeguchi & Adrienne I. Victor & Thach-Giao Truong & Bartosz... (2023)
- Oncolytic Immunotherapy with Nivolumab in Muscle-invasive Bladder Cancer: a Phase 1B Trial — Roger Li & Nancy Y. Villa & Xiaoqing Yu & Joseph O. Johnson & Gustavo Borjas & Jasreman Dhillon & Carlos M. Moran-Segura & Youngchul Kim & Natasha Francis & Denise Dorman & John J. Powers & Wade J. Sexton & Philippe E. Spiess & Michael A. Poch & Logan... (2025)